Volume 39 Issue 4
Apr.  2023
Turn off MathJax
Article Contents
Chen ZY,Hu SQ,Liu DW,et al.Research advances on severe burn infection and cytokine storm[J].Chin J Burns Wounds,2023,39(4):391-395.DOI: 10.3760/cma.j.cn501225-20220412-00134.
Citation: Chen ZY,Hu SQ,Liu DW,et al.Research advances on severe burn infection and cytokine storm[J].Chin J Burns Wounds,2023,39(4):391-395.DOI: 10.3760/cma.j.cn501225-20220412-00134.

Research advances on severe burn infection and cytokine storm

doi: 10.3760/cma.j.cn501225-20220412-00134
Funds:

Regional Science Fund Project of National Natural Science Foundation of China 81460293

More Information
  • Mortality due to severe burns has always been at a high level. A large number of studies have shown that the rapid onset of infectious symptoms and rapid progression of severely burned patients are closely related to the occurrence of cytokine storm. However, in clinical practice, cytokine storm monitoring, early warning, and symptomatic treatment are still in exploratory stage. This article reviews the cytokine storm and its related cytokines, the mechanism, early warning, and treatment of cytokine storm induced by burn infection, aiming to provide clinical references for reducing infection and mortality in severely burned patients.

     

  • loading
  • [1]
    TianH,WangLX,XieWG, et al. Epidemiologic and clinical characteristics of severe burn patients: results of a retrospective multicenter study in China, 2011-2015 [J/OL]. Burns Trauma, 2018,6:14[2022-04-12]. https://pubmed.ncbi.nlm.nih.gov/29850643/.DOI: 10.1186/s41038-018-0118-z.
    [2]
    YoonJ,KymD,HurJ,et al.Comparative usefulness of sepsis-3, burn sepsis, and conventional sepsis criteria in patients with major burns[J].Crit Care Med,2018,46(7):e656-e662.DOI: 10.1097/CCM.0000000000003144.
    [3]
    吴田田,童亚林,姚咏明.烧伤创面脓毒症的防治对策[J].创伤外科杂志,2017,19(5):396-400.DOI: 10.3969/j.issn.1009-4237.2017.05.020.
    [4]
    SapanHB,PaturusiI,JusufI,et al.Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome (MODS) in polytrauma[J].Int J Burns Trauma,2016,6(2):37-43.
    [5]
    FerraraJL.Cytokine dysregulation as a mechanism of graft versus host disease[J].Curr Opin Immunol,1993,5(5):794-799.DOI: 10.1016/0952-7915(93)90139-j.
    [6]
    姚咏明,张卉,李春盛.脓毒症治疗新策略:免疫调理研究新认识[J].医学与哲学,2017,38(2B):28-31,42.DOI: 10.12014/j.issn.1002-0772.2017.02b.04.
    [7]
    中国医疗保健国际交流促进会急诊医学分会,中华医学会急诊医学分会,中国医师协会急诊医师分会,等.中国脓毒症早期预防与阻断急诊专家共识[J].中国急救医学,2020,40(7):577-588.DOI: 10.3969/j.issn.1002-1949.2020.07.001.
    [8]
    王玉亮,王峰,耿洁.细胞因子与细胞因子风暴[J].天津医药,2020,48(6):494-499.DOI: 10.11958/20200323.
    [9]
    TisoncikJR,KorthMJ,SimmonsCP,et al.Into the eye of the cytokine storm[J].Microbiol Mol Biol Rev,2012,76(1):16-32.DOI: 10.1128/MMBR.05015-11.
    [10]
    ZhouHT,LuXY,HuangJ,et al.Induction of trained immunity protects neonatal mice against microbial sepsis by boosting both the inflammatory response and antimicrobial activity[J].J Inflamm Res,2022,15:3829-3845.DOI: 10.2147/JIR.S363995.
    [11]
    MulderPPG,VligM,BoekemaBKHL,et al.Persistent systemic inflammation in patients with severe burn injury is accompanied by influx of immature neutrophils and shifts in T cell subsets and cytokine profiles[J].Front Immunol,2021,11:621222.DOI: 10.3389/fimmu.2020.621222.
    [12]
    唐远洋,罗高兴,贺伟峰.严重烧伤感染后细胞因子风暴发生发展机制浅析[J].四川大学学报(医学版),2021,52(1):16-21.DOI: 10.12182/20210160206.
    [13]
    PandolfiF,AltamuraS,FrosaliS,et al.Key role of DAMP in inflammation, cancer, and tissue repair[J].Clin Ther,2016,38(5):1017-1028.DOI: 10.1016/j.clinthera.2016.02.028.
    [14]
    TeacheyDT,LaceySF,ShawPA,et al.Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia[J].Cancer Discov,2016,6(6):664-679.DOI: 10.1158/2159-8290.CD-16-0040.
    [15]
    DucharmeJ,SelfWH,OsbornTM,et al.A multi-mRNA host-response molecular blood test for the diagnosis and prognosis of acute infections and sepsis: proceedings from a clinical advisory panel[J].J Pers Med,2020,10(4):266.DOI: 10.3390/jpm10040266.
    [16]
    AhmedAI,SolimanRA,SamirS.Cell free DNA and procalcitonin as early markers of complications in ICU patients with multiple trauma and major surgery[J].Clin Lab,2016,62(12):2395-2404.DOI: 10.7754/Clin.Lab.2016.160615.
    [17]
    JonssonN,NilsenT,Gille-JohnsonP,et al.Calprotectin as an early biomarker of bacterial infections in critically ill patients: an exploratory cohort assessment[J].Crit Care Resusc,2017,19(3):205-213.
    [18]
    胡时强,毛远桂,刘德伍,等.严重烧伤脓毒症诊治的研究进展[J].江西医药,2019,54(3):286-288,291.DOI: 10.3969/j.issn.1006-2238.2019.3.034.
    [19]
    LeeDW,GardnerR,PorterDL,et al.Current concepts in the diagnosis and management of cytokine release syndrome[J].Blood,2014,124(2):188-195.DOI: 10.1182/blood-2014-05-552729.
    [20]
    BaranP,HansenS,WaetzigGH,et al.The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling[J].J Biol Chem,2018,293(18):6762-6775.DOI: 10.1074/jbc.RA117.001163.
    [21]
    DholariaBR,BachmeierCA,LockeF.Mechanisms and management of chimeric antigen receptor T-cell therapy-related toxicities[J].BioDrugs,2019,33(1):45-60.DOI: 10.1007/s40259-018-0324-z.
    [22]
    ShankBR,DoB,SevinA,et al.Chimeric antigen receptor T cells in hematologic malignancies[J].Pharmacotherapy,2017,37(3):334-345.DOI: 10.1002/phar.1900.
    [23]
    TanakaY,Martin MolaE.IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab[J].Ann Rheum Dis,2014,73(9):1595-1597.DOI: 10.1136/annrheumdis-2013-205002.
    [24]
    ShakooryB,CarcilloJA,ChathamWW,et al.Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase Ⅲ trial[J].Crit Care Med,2016,44(2):275-281.DOI: 10.1097/CCM.0000000000001402.
    [25]
    LeventogiannisK,KyriazopoulouE,AntonakosN,et al.Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial[J].Cell Rep Med,2022,3(11):100817.DOI: 10.1016/j.xcrm.2022.100817.
    [26]
    ChuWM.Tumor necrosis factor[J].Cancer Lett,2013,328(2):222-225.DOI: 10.1016/j.canlet.2012.10.014.
    [27]
    Cabrera-RiveraGL,Madera-SandovalRL,León-PedrozaJI,et al.Increased TNF-α production in response to IL-6 in patients with systemic inflammation without infection[J].Clin Exp Immunol,2022,209(2):225-235.DOI: 10.1093/cei/uxac055.
    [28]
    MakosA,KuiperJH,KehoeO,et al.Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors[J].Inflammopharmacology,2023,31(1):77-87.DOI: 10.1007/s10787-022-01092-x.
    [29]
    ConfalonieriM,SaltonF,FabianoF.Acute respiratory distress syndrome[J].Eur Respir Rev,2017,26(144):160116.DOI: 10.1183/16000617.0116-2016.
    [30]
    BatzofinBM,SprungCL,WeissYG.The use of steroids in the treatment of severe sepsis and septic shock[J].Best Pract Res Clin Endocrinol Metab,2011,25(5):735-743.DOI: 10.1016/j.beem.2011.05.006.
    [31]
    HemingN,SivanandamoorthyS,MengP,et al.Immune effects of corticosteroids in sepsis[J].Front Immunol,2018,9:1736.DOI: 10.3389/fimmu.2018.01736.
    [32]
    HeF,SongY,YingWJ,et al.Effects of Ulinastatin on myocardial oxidative stress and inflammation in severely burned rats[J].Eur Rev Med Pharmacol Sci,2018,22(17):5719-5728.DOI: 10.26355/eurrev_201809_15840.
    [33]
    ChiYF,LiuXY,ChaiJK.A narrative review of changes in microvascular permeability after burn[J].Ann Transl Med,2021,9(8):719.DOI: 10.21037/atm-21-1267.
    [34]
    LongbrakeEE,HaflerDA.Siponimod chips away at progressive MS[J].Cell,2019,179(7):1440.DOI: 10.1016/j.cell.2019.11.034.
    [35]
    GauthierJ,HirayamaAV,PurusheJ,et al.Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure[J].Blood,2020,135(19):1650-1660.DOI: 10.1182/blood.2019002936.
    [36]
    StaedtkeV,BaiRY,KimK,et al.Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome[J].Nature,2018,564(7735):273-277.DOI: 10.1038/s41586-018-0774-y.
    [37]
    GrazioliA,AthaleJ,TanakaK,et al.Perioperative applications of therapeutic plasma exchange in cardiac surgery: a narrative review[J].J Cardiothorac Vasc Anesth,2020,34(12):3429-3443.DOI: 10.1053/j.jvca.2020.01.054.
    [38]
    肖刘牛,钟燕霞,李树生.体外血液净化技术对脓毒症临床预后及细胞因子影响的Meta分析[J].临床荟萃,2022,37(1):5-13.DOI: 10.3969/j.issn.1004-583X.2022.01.001.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Article Metrics

    Article views (273) PDF downloads(42) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return